Book Now
Book Now
Home API Lapatinib di tosylate

Lapatinib di tosylate

Enquire Now

[anr_nocaptcha g-recaptcha-response]

Product CAS No

231277-92-2

Product Description

Lapatinib is classified as a signal transduction inhibitor – tyrosine kinase inhibitor, an inhibitor of EGFR and HER2.

Therapeutic Action

Lapatinib used in the form of lapatinib ditosylate, It is an orally active drug for breast cancer and other solid tumors. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress.

About Company

Bulat Pharmaceutical founded in 2017, is a technological enterprise engaged in the R&D, production and marketing of pharmaceutical raw materials.

Newsletter

Products

APIs
Formulation
Intermediate

Quick Links

Connect Us

Bulat Pharmaceutical Pvt. Ltd.
Unit No. 411 , Tower-A 4th Floor,
Spaze DGE Sector 47 ,Sohna Road,
Gurugram, Haryana.

Tel:-+91-8448085659
E-mail:-[email protected]

© 2021 Bulat Pharmaceutical.

Enquire Now
close slider


[anr_nocaptcha g-recaptcha-response]




  • →
  • INQUIRY FORM

    INQUIRY FORM